Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis

Laryngoscope

Volumn 107, Issue 1, 1997, Pages 95-100

  Wirtschafter, Ari ^a   Schmidt, Richard ^a   Rosen, David ^a   Kundu, Nandita ^a   Santoro, Massimo ^b   Fusco, Alfredo ^b   Multhaupt, Hinke ^c   Atkins, Joseph P ^a   Rosen, Marc R ^a   Keane, William M ^a   Rothstein, Jay L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CHIETI   (Italy)

^c PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Hashimoto's thyroiditis; Oncogene; Papillary thyroid carcinoma; RET PTC fusion gene; Thyroid gland

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE FUSION; GENETIC MARKER; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

ADULT; AGED; CARCINOMA, PAPILLARY; DNA PRIMERS; DROSOPHILA PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031031158     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199701000-00019     Document Type: Article

References (16)

1. Becker KL. Principles and Practices of Endocrinology and Metabolism. 2nd ed. Philadelphia: J.B. Lippincott Co., 1995: 414-417.
2. Ott RA, McCall AR, McHenry C, et al. The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg. 1987;53: 442-445.
3. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto's disease of the thyroid gland. AMA Arch Surg. 1955;70:291-297.
4. Jhiang SM, Mazzaferri EL. The RET/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med. 1994;123:331-337.
5. Bongarzone I, Butti MG, Coronelli S, et al. Frequent activation of RET protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res. 1994;54:2979-2985.
6. Mulligan LM, Kwok JBJ, Healey CS, et al. Germ-line mutations of the c-RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993;363:458-460.
7. Santoro M, Carlomagno F, Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest. 1992;89:1517-1522.
8. Bongarzone I, Butti MG, Coronelli S, et al. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res. 1994;54:2979-2985.
9. Tsuzuki T, Takahashi M, Asai N, et al. Spatial and temporal expression of the c-RET proto-oncongene product in embryonic, infant and adult rat tissues. Oncogene. 1995;10:191-198.
10. Pachnis V, Mankoo B, Constantini F. Expression of the c-RET proto-oncogene during mouse embryogenesis. Development. 1993;119:1005-1017.
11. Viglietto G, Chiappetta G, Martinez-Tello FJ, et al. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene. 1995;11:1207-1210.
12. Sibbitt WL Jr. Oncogenes, growth factors, and autoimmune diseases (review). Anticancer Res. 1991;11:97-114.
13. Rothstein JL, Johnson D, Skowronski J, et al. Construction of primary and subtracted cDNA libraries from early embryos. Methods Enzymol. 1993;225:587-610.
14. Sozzi G, Miozzo M, Pastorino U, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res. 1995;55:135-140.
15. Jhiang SM, Smanik PA, Mazzaferri EL. Development of a single-step duplex RT-PCR detecting different forms of ret activation and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma. Cancer Lett. 1994;78:69-76.
16. Fugazzola L, Pilotti S, Pinchera A, et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chemobyl nuclear accident. Cancer Res. 1995;55:5617-5620.